Has Irene Malaty, MD received payments from drug or device companies?

Yes. Drug and device makers reported $282,338 in general payments to Irene Malaty, MD across 70 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Irene Malaty, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Irene Malaty, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Irene Malaty, MD

Neurology · Gainesville, FLNPI 1134295694

Payments from drug & device makers

$282,338in general payments, 2019–2025

Across 70 payments — averaging $4033.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$201K
Sage Therapeutics, LLC$79K
Acadia Pharmaceuticals Inc$2K
CSL Behring$20

What the payments were for

Consulting fees$30,60093%
Travel & lodging$1,8516%
Food & beverage$5022%
Education$250%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	57	$201,290
Sage Therapeutics, LLC	8	$79,223
Acadia Pharmaceuticals Inc	4	$1,805
CSL Behring	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VYALEV$20,664
NUPLAZID$1,800
Duopa$800

How this compares

$282,338 in reported general payments places this provider in the 85th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Medicare billing

Part B allowed, 2024

$760,290

Medicare patients

350

Services billed

98,851

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
AustedoDeutetrabenazine	22	$157,805
RytaryCarbidopa/Levodopa	16	$19,022
Carbidopa	11	$7,409
Carbidopa-LevodopaCarbidopa/Levodopa	114	$7,111
Carbidopa-Levodopa ErCarbidopa/Levodopa	39	$1,773
Clozapine	70	$1,766
Selegiline Hcl	13	$1,215
Primidone	19	$965
AmantadineAmantadine Hcl	22	$477
Clonazepam	35	$261
Escitalopram Oxalate	18	$249
Topiramate	27	$248
Sertraline Hcl	23	$150
Gabapentin	18	$121
Citalopram HbrCitalopram Hydrobromide	13	$64

Paid to pharmacies, not to this prescriber.

Other neurology in Gainesville

Torge RempeGainesville$3.6M
Mark GoldsteinAtlantis$36.1M
Derrick RobertsonTampa$27.6M
Beth SafirsteinHallandale Beach$25.7M
Michael PfefferMiami$24.5M
Mark BrodyDelray Beach$20.5M
Paayal PatelWest Palm Beach$17.3M
Wendy BondFort Myers$14.7M
William HoneycuttMaitland$14.1M
Julie SchwartzbardAventura$13.6M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →